The Primary
Care Companionfor CNS Disorders

Psychiatry

Educational Activity February 1, 2004

CME Instructions and Posttest

Prim Care Companion J Clin Psychiatry 2004;6(suppl 1):25-26

Article Abstract

CME Instructions and Posttest February 2004

This CME activity is expired. For more CME activities, visit cme.psychiatrist.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

View Related Activity

Go to Activity

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 27 • 2025 • Number 1

Read the Current Issue

Case Report

Thyrotoxic Psychosis in Graves’ Disease

Rounds in the General Hospital

Psychosis-Related PTSD

Case Report

Factitious Disorder in the Context of Abuse in an Adolescent

Rounds in the General Hospital

Wishing That Your Patient Would Die: Reasons and Reactions

Case Report

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Case Report

Low-Dose Clozapine in Schizophrenia With Aggression

View current Issue

Educational Activity

Treatments for OFF Episodes in Parkinson Disease

December 1, 2020

After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy "wears off." How can you increase their ON time? In this...

Rajesh Pahwa , Stuart H. Isaacson

Educational Activity

Evaluating Patients for TD

December 1, 2020

Although clinicians are pressed for time, diligence in assessing for tardive dyskinesia in patients taking antipsychotics is crucial, especially now that treatment is available. In this brief CME activity,...

Andrew A. Nierenberg

Educational Activity

Recognizing and Assessing Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

September 28, 2016

Bradley Gaynes

CME Instructions and Posttest

Read the Current Issue

Thyrotoxic Psychosis in Graves’ Disease

Psychosis-Related PTSD

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

ELSEWHERE:

FOLLOW US:

CME Instructions and Posttest

Read the Current Issue

Thyrotoxic Psychosis in Graves’ Disease

Psychosis-Related PTSD

Factitious Disorder in the Context of Abuse in an Adolescent

Wishing That Your Patient Would Die: Reasons and Reactions

Frontal Lobe Syndrome Unveils an Unexpected Diagnosis

Low-Dose Clozapine in Schizophrenia With Aggression

Related Articles

Treatments for OFF Episodes in Parkinson Disease

Evaluating Patients for TD

Recognizing and Assessing Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles